Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma

Published:2019-07-18 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jin Yu,Wong Ye Shen,Goh Brian K. P.,Chan Chung Yip,Cheow Peng Chung,Chow Pierce K. H.^ORCID,Lim Tony K. H.,Goh George B. B.,Krishnamoorthy Thinesh Lee,Kumar Rajneesh,Ng Tze Pin,Chong Samuel S.,Tan Hwee Huang,Chung Alexander Y. F.,Ooi London Lucien P. J.,Chang Jason P. E.,Tan Chee Kiat^ORCID,Lee Caroline G. L.

Funder

Agency for Science, Technology and Research

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-46872-8.pdf

Reference63 articles.

1. Wong, M. C. et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep 7, 45846, https://doi.org/10.1038/srep45846 (2017).

2. Dhanasekaran, R., Limaye, A. & Cabrera, R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4, 19–37, https://doi.org/10.2147/HMER.S16316 (2012).

3. Sanyal, A. J., Yoon, S. K. & Lencioni, R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15(Suppl 4), 14–22, https://doi.org/10.1634/theoncologist.2010-S4-14 (2010).